参考文献/References:
[1] Anton ES, Weskamp G, Reichardt LF, et al. Nerve growth
factor and its low-affinity receptor promote Schwann cell
migration [J]. Proc Natl Acad Sci USA, 1994, 91(7): 2795-
2799.
[2] 魏传银,王丽梅,陈雪红,等. 神经营养素受体p75NTR介导
的信号转导[J]. 细胞与分子免疫学杂志,2005,21(2):
258-260.
[3] Wang H, Wang R, Thrimawithana T, et al. The nerve growth
factor signaling and its potential as therapeutic target for
glaucoma [J]. Biomed Res Int, 201: 759473.
[4] Friedman WJ, Greene LA. Neurotrophin signaling via Trks
and p75 [J]. Exp Cell Res, 1999, 253(1): 131-142.
[5] Segal RA, Greenberg ME. Intracellular signaling pathways
activated by neurotrophic factors [J]. Annu Rev Neurosci,
1996, 19: 463-489.
[6] Hendry IA. Retrograde factors in peripheral nerves [J].
Pharmacol Ther, 1992, 56(3): 265-285.
[7] Ross AH, Lachyankar MB, Poluha DK, et al. Axonal trans-
port of the trkA high-affinity NGF receptor [J]. Prog Brain
Res, 1994, 103: 15-21.
[8] Bothwell M. Functional interactions of neurotrophins and
neurotrophin receptors [J]. Annu Rev Neurosci, 1995, 18:
223-253.
[9] Ehlers MD, Kaplan DR, Price DL, et al. NGF-stimulated
retrograde transport of trkA in the mammalian nervous
system [J]. J Cell Biol, 1995, 130(1): 149-156.
[10] Johanson SO, Crouch MF, Hendry IA. Retrograde axonal
transport of signal transduction proteins in rat sciatic nerve
[J]. Brain Res, 1995, 690(1): 55-63.
[11] 徐 莉,饶春明. 神经生长因子的研究进展[J]. 中国生物
制品学杂志,2014,27(1):131-134.
[12] 彭 形. 神经生长因子生物学效应的研究进展[J]. 检验医
学与临床,2009,6(3):203-204.
[13] 朱 奕,王 彤. 神经生长因子的生物学效应及其在脑损
伤康复中的研究进展[J]. 中国康复医学杂志,2005,20
(6):474-476.
[14] Guegan C, Ceballos-Picot I, Chevalier E, et al. Reduction of
ischemic damage in NGF-transgenic mice: correlation with
enhancement of antioxidant enzyme activities [J]. Neurobiol
Dis, 1999, 6(3): 180-189.
[15] 黄俊红,谭翱勇,谭占国. 神经生长因子在中枢神经功能
修复中的研究进展[J]. 中国实用神经疾病杂志,2014,17
(19):126-127.
[16] Lindholm D, Mercer EA, Yu LY, et al. Neuronal apoptosis
inhibitory protein: structural requirements for hippocalcin
binding and effects on survival of NGF-dependent sympa-
thetic neurons [J]. Biochim Biophys Acta, 2002, 1600(1-2):
138-147.
[17] 周 健,孙克华. 神经损伤后的再生与神经营养因子[J].
中国微侵袭神经外科杂志,2006,11(1):36-38.
[18] Banks WA, Kastin AJ. Exchange of peptides between the
circulation and the nervous system: role of the blood-brain
barrier [J]. Adv Exp Med Biol, 1990, 274: 59-69.
[19] Pan W, Banks WA, Kastin AJ. Permeability of the blood-
brain barrier to neurotrophins [J]. Brain Res, 1998, 788(1-
2): 87-94.
[20] Fabian RH, Hulsebosch CE. Plasma nerve growth factor
access to the postnatal central nervous system [J]. Brain
Res, 1993, 611(1): 46-52.
[21] 李 兵,鲁晓杰,陈 建,等. 神经生长因子在大鼠脑损伤
后血脑屏障的通透性[J]. 中华神经外科疾病研究杂志,
2008,7(3):216-219.
[22] 朱文平,林宜生,黄芸生,等. 神经生长因子治疗急性重型
颅脑外伤的疗效[J]. 广东医学,2001,22(10):915-916.
[23] 韩宗利,王 诚,刘 胜,等. 神经生长因子在颅脑损伤救
治中的应用[J]. 骨科,2009,33(3):134-136.
[24] Nomura H, Tator CH, Shoichet MS. Bioengineered strategies
for spinal cord repair [J]. J Neurotrauma, 2006, 23(3-4):
496-507.
[25] Bayir H, Clark RS, Kochanek PM. Promising strategies to
minimize secondary brain injury after head trauma [J]. Crit
Care Med, 2003, 31(1): S112-S117.
[26] 蒋天伟. 神经生长因子在重型颅脑损伤救治中的应用[J].
中国实用神经疾病杂志,2012,15(9):64-65.
[27] 章 翔,费 舟,王占祥,等. 重型颅脑损伤临床救治经
验[J]. 中华神经外科疾病研究杂志,2003,2(3):203-207.
[28] 徐如祥. 脑损伤神经功能损害与修复专家共识[J]. 中华神
经创伤外科电子杂志,2016,2(2):100-104.
[29] 冼成恩,刘 胜. 神经生长因子在颅脑外伤中的应用进展
[J]. 中国现代医生,2013,51(11):29-31.
[30] Albert T, Ravaud JF. Rehabilitation of spinal cord injury in
France: a nationwide multicentre study of incidence and
regional disparities [J]. Spinal Cord, 2005, 43(6): 357-365.
[31] 赵 澎,胡 微,乌尤图,等. 神经保护剂的应用与评价
[J]. 中华神经外科疾病研究杂志,2015,14(2):188-189.
[32] 孙天胜. 《新鲜胸腰段脊柱脊髓损伤评估与治疗》的专家
共识[J]. 中国脊柱脊髓杂志,2011,21(11):963-968.
[33] 金 海,侯立军. 颅脑外伤合并颅神经损伤的研究[J]. 国
际神经病学神经外科学杂志,2008,35(2):185-188.
[34] 刘卫平,伊西才,甄海宁,等. 鼠神经生长因子预防颅脑损
伤后功能障碍临床观察[J]. 中华神经医学杂志,2010,9
(2):193-195.
相似文献/References:
[1]韩芸峰 综述 王振宇 于 涛 审校.NGF及其受体在脊髓损伤后神经源性肠功能障碍中的研究现状[J].中国临床神经外科杂志,2015,(11):673.[doi:10.13798/j.issn.1009-153X.2015.11.011]
[2]左积文 韩岳 陈丽丽 张庆九 戎晓玲 李玉芳.神经生长因子联合奥拉西坦治疗中老年高血压性脑出血的疗效分析[J].中国临床神经外科杂志,2017,(10):711.[doi:10.13792017.09/j.issn.1009-153X.2017.10.014]
[3]陈 旭 杨 旭.依达拉奉联合神经生长因子治疗重型颅脑损伤的疗效分析[J].中国临床神经外科杂志,2018,(07):479.[doi:10.13798/j.issn.1009-153X.2018.07.009]
CHEN Xu,YANG Xu..Effect of edaravone combined with nerve growth factor on patients with severe craniocerebral injury[J].,2018,(11):479.[doi:10.13798/j.issn.1009-153X.2018.07.009]